期刊文献+

原发性骨髓纤维化早期患者骨髓形态学特征研究 被引量:12

The morphology features of bone marrow in the prefibrotic-early primary myelofibrosis
原文传递
导出
摘要 目的 比较原发性骨髓纤维化(PMF)早期患者与原发性血小板增多症(ET)患者骨髓细胞形态学特征,并探讨JAK2V617F突变对骨髓细胞形态的影响.方法 收集接受一般药物治疗并转化为纤维化明显期的7例PMF早期患者标本,分析其骨髓形态学特征.依据2008年WHO诊断标准,对2003年1月至2011年3月同步进行骨髓涂片、印片与切片检查的156例(疑似)ET患者标本重新分类,并双盲分析PMF早期与ET患者骨髓形态学差异.收集行JAK2V617F突变检测的22例PMF早期患者与27例ET患者标本,双盲比较JAK2V617F突变型与野生型骨髓形态学差异.结果 156例(疑似)ET患者标本中PMF早期61例(MF-0为34例,MF-1为27例)、PMF明显期12例、ET83例.MF-1组患者血小板计数[(1134 +391)×109/L]、血清乳酸脱氢酶水平[(727±241)U/L]显著高于ET组[(973±242)×109/L,(392±146)U/L] (P <0.05).MF-1组患者骨髓涂片中原始细胞比例(0.012±0.010)显著高于ET组(0.006+0.004)(P<0.05).MF-0与MF-1组患者骨髓切片示有核细胞(粒细胞)总量增多、紧密型巨核细胞簇、骨小梁旁巨核细胞、云雾状巨核细胞、小裸核巨核细胞、大单圆核巨核细胞的检出率均显著高于ET组,而疏松型巨核细胞簇、巨大多分叶核巨核细胞的检出率均显著低于ET组(P值均<0.05);MF-1组患者巨核细胞簇伴异形性改变的检出率显著高于MF-0与ET组(P值均<0.05).PMF早期与ET患者JAK2V617F突变阳性率分别为54.5%与48.1%.PMF早期与ET组突变型患者HGB水平均高于野生型(P值均<0.05),而巨核细胞形态在突变型中均未见明显异形性改变.结论 骨髓切片形态学(尤其是巨核细胞形态学)是PMF早期与ET鉴别诊断的基础,形态学参数的重要性排序依次为巨核细胞簇伴异形性、云雾状巨核细胞、大单圆核巨核细胞、有核细胞(粒细胞)总量增多、小裸核巨核细胞、骨小梁旁巨核细胞及紧密型巨核细胞簇. Objective To compare the morphologic features of bone marrow (BM) between the prefibrotic-early primary myelofibrosis (PMF) and essential thrombocythaemia (ET). Method Seven cases of prefibrotic-early PMF were selected and analyzed. Based on the diagnostic standard of prefibrotic-early PMF by WHO, BM aspirate smears, trephine biopsy sections and imprints of 156 uncertain ET cases conducted simultaneously were recruited into this study, the BM morphologic features between the prefibrotic-early PMF and ET groups were analyzed. The morphological difference in 22 cases of prefibrotic-early PMF and 27 ET were compared between the JAK2V617F mutation positive and negative groups. Results Of the 156 uncertain ET cases, it was reclassified 61 prefibrotic-early PMF (34 MF-0, 27 MF-1 ), 12 PMF and 83 ET. The platelet count and LDH level in MF-1 group were obviously higher than that of ET group ( P 〈 0.05 ). The blast percentage of BM smear in MF-1 group was also higher than that of ET group ( P 〈 0.05 ). As to BM section, cases with increased nucleated cells (granulocyte), compact megakaryocytic cluster, megakaryocyte near bone trabecula, cloud-like megakaryocyte, small bare nucleus of megakaryocyte and large ball-like megakaryocyte in MF-0 and MF-1 group were significantly higher than that of ET group ( all P 〈 0.05 ), cases with megakaryocytic cluster of various size in MF-1 group were significantly higher than that of MF-0 and ET groups(P 〈0.05). The JAK2V617F mutation rate in prefibrotic-early PMF and ET groups were 54.5% and 48.1% , respectively. Hb level in JAK2V617F mutation positive group was obviously higher than the negative group (P 〈 0. 05 ) , no special change with megakaryocytic morphology was found between the positive and negative groups. Conclusion Morphology of BM section, especially megakaryocytic morphologic characteristics are the main basis in distinguishing prefibrotic-early PMF from ET. The importance of morphologic index were megakaryocytic cluster with various size, cloud-like megakaryocyte, large ball-like megakaryocyte, increased nucleated cells (granulocyte), small bare nucleus, megakaryocyte near bone trabecula and compact megakaryocytic cluster in order. JAK2V617F mutation provides no specific effect on the megakaryocytic morphology.
出处 《中华血液学杂志》 CAS CSCD 北大核心 2012年第1期25-30,共6页 Chinese Journal of Hematology
关键词 骨髓纤维化 血小板增多 巨核细胞 Myelofibrosis Thrombocythaemia Megakaryocyte
  • 相关文献

参考文献15

  • 1Swerdlow SH,Campo E,Harris NL,et al.World Health Organization Classification of Tumors Pathology and genetics of tumors of haematopoietie and lymphoid tissues.4th ed.Lyon:IARC press,2008.
  • 2Spivak JL,Siver RT.The revised World Health Organization diagnostic criteria for polycythemia vera,essential thrombocytosis and primary myelofibrosis:an alternative proposal.Blood,2008,112:231-239.
  • 3Thiele J,Kvasnicka HM,Zankovich R,et al.Relevance of bone marrow features in the differential diagnosis between essential thrombocythemia and early stage idiopathic myelofibrosis.Haematologica,2000,85:1126-1134.
  • 4Wilkins BS,Erber WN,Bareford D,et al.Bone marrow pathology in essential thrombocythemia:interobserver reliability and utility for identifying disease subtypes.Blood,2008,111:60-70.
  • 5Gong X,Lu X,Wu X,et al.Role of bone marrow imprints in haematological diagnosis:a detailed study of 3781 cases.Cytopathology 2010 Dec 3.doi:10.111 1/j.1365-2303.2010.00825.x.[Epub ahead of print].
  • 6龚旭波,吴先国,卢兴国,严丽娟,吴东,肖希斌,王炜琴,王林.CD41标记微小巨核细胞染色法及其临床应用价值探讨[J].中华血液学杂志,2008,29(6):420-422. 被引量:9
  • 7Shin M,Izumi S,Nakane PK. Multilayer peroxidase-labeled antibody method:comparison with labeled streptavidin-biotin method,avidin-biotin-peroxidase complex method,and peroxidase-antiperoxidase method.J Clin Lab Anal,1995,9:424-430.
  • 8Lee SH,Erber WN,Porwit A,et al.ICSH guidelines for the standardization of bone marrow specimens and reports.Int J Lab Hematol,2008,30:349-364.
  • 9Brousseau M,Parot-Schinkel E,Moles MP,et al.Practical application and clinical impact of the WHO histopathological criteria on bone marrow biopsy for the diagnosis of essential thrombocythemia versus prefibrotic primary myelofibrosis.Histopathology,2010,56:758-767.
  • 10Stauffer Larsen T,HasseLbalch HC,Pallisgaard N,et al.Bone marrow histomorphology and JAK2 mutation status in essential thrombocythemia.APMIS,2007,115:1267-1273.

二级参考文献3

  • 1Das R, Hayer J, Dey P, et al. Comparative study of myelodysplastic syndromes and normal bone marrow biopsies with conventional staining and immunocytochemistry. Anal Quant Cytol Histol, 2005, 27:152-156.
  • 2Levine RF, Olson TA, Shoff PK, et al. Mature micromegakaryocytes: an unusual developmental pattern in term infants. Br J Haematol, 1996, 94:391-399.
  • 3Cooper K, Haffajee Z, Taylor L. Comparative analysis of biotin intranuclear inclusions of gestational endometrium using the APAAP, ABC and the PAP immunodetection systems. Clin Pathol, 1997, 50:153-156.

共引文献8

同被引文献108

引证文献12

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部